The cost per patient in patients with neutropenia, lymphopenia, elevated ferritin, CRP > 41.8 mg/L and those patients who died was significantly (p = 0.000) higher than that in patients who did not have these outcomes (Supplementary Table S2). This evidence concerns the gene CRP and Decreased total neutrophil count.